Litigation Details for Tris Pharma Inc. v. Actavis Laboratories FL Inc. (D. Del. 2014)
✉ Email this page to a colleague
Tris Pharma Inc. v. Actavis Laboratories FL Inc. (D. Del. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-10-15 |
Court | District Court, D. Delaware | Date Terminated | 2017-09-05 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 8,465,765; 8,563,033; 8,778,390; 8,956,649; 9,040,083 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Tris Pharma Inc. v. Actavis Laboratories FL Inc.
Details for Tris Pharma Inc. v. Actavis Laboratories FL Inc. (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-11-29 | 201 | Opinion - Memorandum Opinion | in five patents: U.S. Patent Nos. 8,465,765 (the #765 patent), 8,563,033 (the #033 patent), 8,778,390…,390 (the #390 patent), 8,956,649 (the #649 patent), and 9,040,083 (the #083 patent}. Tris Pharma, Inc… #033 patent, claims 6 and 20 of the #765 patent, and claims 15, 16, and 20 of the #390 patent. The Federal… the #033 patent, claim 6 of the #765 patent, and claims 15, 16, and 20 of the #390 patent. Actavis… the #033 patent, claim 6 of the #765 patent, and claims 15, 16, and 20 of the #390 patent are invalid | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |